• Vancouver Tech Journal
  • Posts
  • Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment

Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment

Plus, it generated a net profit of $119 million USD, up from a net loss of $2 million on $11.6 million in revenue.

Author

William Johnson
March 29, 2021

logo

Subscribe to Premium to read the rest.

Become a paying subscriber of Premium to get access to this post and other subscriber-only content.

Upgrade

A subscription gets you:

  • ♥️ Supporting Vancouver's tech community
  • 🔑 Exclusive content: In-depth stories that you won’t find anywhere else
  • 🎟 First access to events we put on
  • 🔓 Daily Briefings: The Morning Report, an email digest of need-to-know stories and deals
  • 🧠 Monthly members-only virtual Q&As with investors, founders, and operators
  • 🗓 Discounted and invitation-only events
Already a subscriber?Sign In.